| Disease | differentiated thyroid carcinoma |
| Phenotype | C0001418|adenocarcinoma |
| Sentences | 1 |
| PubMedID- 26403409 | Imp3 is also considered a prognostic biomarker in patients with renal cell carcinoma and clear-cell type ovarian carcinoma, hepatocellular carcinoma, pancreatic ductal adenocarcinoma and in patients with poorly differentiated thyroid carcinoma and uterine cervical carcinomas, testicular cancer and malignant melanoma. |
Page: 1